Helius medical technologies, inc. compliant with nasdaq bid price rule listing criteria

Company previously granted extension until june 30, 2025 to regain compliance with nasdaq's equity rule requirement company previously granted extension until june 30, 2025 to regain compliance with nasdaq's equity rule requirement
NDAQ Ratings Summary
NDAQ Quant Ranking